OCRA in Conversation: Dr. Richard Pazdur, FDA

Audra Moran, President and CEO of OCRA, and Dr. Richard Pazdur, Head of the Oncology Center of Excellence at FDA, shared reflections — both personal and professional — about ovarian cancer during a recent discussion.

Topics that were covered include the critical role that patients play in research, drug regulation, and the policies that affect the ovarian cancer community. They also talked about the progress that has been made in treatments and testing, as well as what is on the horizon that makes them hopeful.

View additional discussions and presentations in our “OCRA in Conversation” video series.

Posted on in OCRA News